Optimization of a negative oral contrast agent for magnetic resonance imaging.
Davis
M A
MA
Department of Radiology, University of Massachusetts Medical Center, Worcester 01655.
Mei
H
H
Ritsema
G H
GH
D000005:Abdomen / Q000033:anatomy & histology; D000284:Administration, Oral; D000818:Animals; D001466:Barium Sulfate / Q000008:administration & dosage; D001546:Bentonite / Q000008:administration & dosage; D003287:Contrast Media / Q000008:administration & dosage*; D003911:Dextrans; D004064:Digestive System / Q000033:anatomy & histology; D052203:Ferrosoferric Oxide; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D010087:Oxides / Q000008:administration & dosage; D011817:Rabbits
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D001546:Bentonite; D001466:Barium Sulfate; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide